HAPTO Biotech Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $8.7M
Latest Deal Amount

HAPTO Biotech General Information

Description

Developer of fibrin derived platform technologies. The company offers Fibrin Micro Beads for stem cell recovery and Haptides for cell attachment to fibrin. It's technology is used in the field of tissue engineering for the repair and replacement of skin and bone.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Medical Supplies
Acquirer
Forticell Bioscience
Primary Office
  • 666 Old Country Road
  • Suite 302
  • Garden City, NY 11530
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HAPTO Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 14-Apr-2006 $8.7M 00.00 Completed
1. Early Stage VC Completed
To view HAPTO Biotech’s complete valuation and funding history, request access »

HAPTO Biotech Executive Team (1)

Name Title Board Seat Contact Info
Gerard Marx Ph.D Vice President & Scientific Co-Founder
To view HAPTO Biotech’s complete executive team members history, request access »

HAPTO Biotech Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioMedical Innovations Management Venture Capital Minority 000 0000 000000 0
Hadasit Bio-Holdings Corporation Minority 000 0000 000000 0
Israel Technology Partners Venture Capital Minority 000 0000 000000 0
Latartech Holdings Venture Capital Minority 000 0000 000000 0
Mediseed Venture Capital Minority 000 0000 000000 0
To view HAPTO Biotech’s complete investors history, request access »